Allosteric modulation of sigma receptors by BH3 mimetics ABT-737, ABT-263 (Navitoclax) and ABT-199 (Venetoclax)

Allosteric modulation of sigma receptors by BH3 mimetics ABT-737, ABT-263 (Navitoclax) and ABT-199 (Venetoclax)

Posted by Leanne Kodsmann on

Innovative Grade US Origin Rat Sprague Dawley Liver from Innovative Research was used in the following study:

 

Allosteric modulation of sigma receptors by BH3 mimetics ABT-737, ABT-263 (Navitoclax) and ABT-199 (Venetoclax)

John R. Lever, Emily A. Fergason-Cantrell

Pharmacological Research
Volume 142, April 2019, Pages 87-100

"... Membranes were prepared from frozen livers (Innovative Research, Inc.; Novi, MI) of male Sprague Dawley rats as detailed by Hellewell et al. [40]. Protein concentrations were determined using a bicinchoninic acid assay kit ..."

 

Related products available from Innovative Research also include:

  • Tags: Animal Tissues Organs, Innovative Grade US Origin Rat Sprague Dawley Liver

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Easy as PAI(-1): Celebrate Pi Day with Cutting-Edge Monoclonal Antibodies from Innovative Research
    In the ever-evolving landscape of molecular biology, precision tools are essential for ...
    Read the Article
    Revolutionizing Diabetes Treatment: Genetically Engineered Pseudo-Islets Achieve Insulin Independence
    In a groundbreaking study, researchers have pioneered a diabetes treatment that could r...
    Read the Article
    Pioneering Advances in Complement-Mediated Disorders: An In-depth Look at SAR443809
    In the dynamic landscape of medical research, SAR443809 emerges as a promising candidat...
    Read the Article

    ← Older Post Newer Post →

    ×